This compound is primarily used in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a fluorophenyl group and an amino acid moiety, makes it valuable in the development of drugs targeting neurological and psychiatric disorders. It is particularly significant in the production of compounds that modulate neurotransmitter systems, such as GABAergic or dopaminergic pathways. Additionally, it serves as a building block in the creation of peptidomimetics, which are designed to mimic the behavior of peptides in therapeutic applications. Its role in medicinal chemistry underscores its importance in the design and optimization of novel drug candidates.